The Texans still don’t know if Joe Mixon will ever suit up again after a bizarre, off-field foot injury erased his 2025 season and now threatens his $9 million 2026 salary.
Nick Caserio’s end-of-season podium session delivered the loudest non-update of the NFL offseason: Joe Mixon’s right foot remains a medical mystery and the Texans have zero timetable for the 29-year-old former Pro Bowl back.
“We haven’t seen Joe in a little bit,” the Houston GM said Wednesday. “I don’t think anybody really had any clarity, honestly, from the start of the year until now.”
How a “freak thing” derailed a $27 million contract
Mixon signed a three-year, $27 million deal in March 2024 after arriving from Cincinnati. He responded with 1,054 rushing yards and a Pro Bowl nod, becoming the first Texans back to top 1,000 yards since Carlos Hyde in 2019.
Then the offseason hit. While away from team facilities, Mixon sustained an undisclosed foot injury the club has never fully explained. The only label Caserio would attach Wednesday: “a freak thing.”
“It wasn’t like he was riding a snowmobile or anything like that,” Caserio added. “It was more of a medical condition or situation that … didn’t improve maybe as much as everybody would have hoped.”
The Texans placed him on the reserve/non-football injury list before Week 1, ending his 2025 campaign before it began. Houston’s medical staff never cleared him to practice, leaving Mixon to rehab on his own for 12 months.
Cap casualty alert: $9 million decision looms
Mixon is scheduled to count $9.01 million against the 2026 cap—a top-eight RB number—while coming off a lost season and still-lingering foot issue. Releasing him pre-June 1 would save $6.75 million with only $2.26 million in dead money, per Over The Cap.
Caserio refused to speculate on whether Mixon will be on the roster come training camp. “I’m not smart enough to be a doctor,” he said, punting the verdict to the team’s medical staff this spring.
Texans survived without him—so why pay premium price?
Houston finished 12-5 and clinched the AFC South despite the vacuum at running back. Rookie Woody Marks led the team with 703 rushing yards, while mid-season pickup Nick Chubb added 506 in just nine games. The committee approach produced a respectable 4.3 yards per carry, ranking 11th league-wide.
That production, combined with a cheaper price tag, makes Mixon’s 2026 salary feel like a luxury the Texans can no longer justify unless he can prove the foot is fully healed and the burst is still there.
Medical red flags that could scare suitors
- No public diagnosis—teams will demand imaging and second opinions.
- Age curve: Running backs historically decline sharply after 29.
- Zero 2025 tape for scouts to evaluate burst or lateral movement.
- Non-football injury tag means no insurance payout if he re-injures.
Mixon’s career résumé—7,428 rushing yards, 60 TDs, 2,448 receiving yards—still carries weight, but GMs fear paying for past production. One AFC scouting director told ESPN that “medical flags on veteran backs can drop trade value to a conditional sixth” if the contract isn’t slashed.
Three offseason outcomes on the table
- June 1 cut: Houston spreads dead money over two years, pockets $7.5 million to chase a cheaper veteran or 2026 draft rookie.
- Pay cut or restructure: Mixon accepts a reduced base salary with incentives tied to active games, preserving roster depth.
- Show-and-prove minicamp: Texans bring him to April workouts, watch medical clearance, then decide before training camp.
All signs point to Option 1 unless Mixon can jog into NRG Stadium next month without a limp and flash the same violent jump-cut that made him a Pro Bowler.
Fan fallout: Fantasy and franchise ripple effects
Redraft players have already scrubbed Mixon from 2026 boards, but dynasty gamers still roster him in 78% of leagues on FantasyData. A release would likely land him in a committee, tanking his already volatile ADP.
For the Texans, clearing Mixon’s cap space could fund an extension for left tackle Laremy Tunsil or a pursuit of a top-tier safety in free agency. Every million counts with quarterback C.J. Stroud’s megadeal looming in 2027.
Bottom line: Joe Mixon’s 2026 outlook is as murky today as it was the moment he stepped on that invisible land mine last offseason. Until Houston’s doctors—and Mixon’s right foot—deliver a clean bill, the only certainty is that the Texans will explore every avenue to avoid paying $9 million for a ghost on the roster.
Stay locked on onlytrustedinfo.com for the fastest, most definitive Texans roster analysis the moment Mixon’s foot—or his contract—moves one way or the other.
